Halma/£HLMA

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Halma

Halma is a global group of life-saving technology companies founded in 1894. This UK-based company specializes in developing and delivering innovative solutions that enhance the protection and improvement of people's health and the environment. Halma operates in the Safety, Medical, and Environmental & Analysis sectors, offering products and technologies that provide critical support in healthcare diagnostics, environmental monitoring, and life protection applications.

Ticker

£HLMA

Primary listing

LSE

Industry

Electronic Equipment, Instruments & Components

Employees

9,000

ISIN

GB0004052071

Halma Metrics

BasicAdvanced
£12B
40.01
£0.78
0.61
£0.22
0.71%

What the Analysts think about Halma

Analyst ratings (Buy, Hold, Sell) for Halma stock.

Bulls say / Bears say

Halma achieved record revenue exceeding £1 billion in the first half of fiscal year 2025, marking a 13% increase, and adjusted EBIT surpassed £200 million, up 17%, indicating strong financial performance. (Seeking Alpha)
The company has a robust M&A strategy, completing four acquisitions totaling £158 million year-to-date, contributing over 4% to EBIT growth in the first half, and maintains a healthy pipeline for future acquisitions. (StockInvest.us)
Halma increased its annual dividend for the 45th consecutive year after a 10% rise in annual profit, reflecting strong financial health and commitment to shareholder returns. (Reuters)
HSBC analyst Stephan Klepp adjusted Halma's price target to £2.60 from £2.65, citing foreign exchange headwinds likely to lead to minor estimate reductions, affecting all UK industrial firms due to the strong British pound. (Investing.com)
Halma's Healthcare sector reported a 1% revenue growth, but experienced a 2.5% decline on an organic constant currency basis, primarily due to weaker performance in eye health therapeutics. (StockInvest.us)
The company's valuation appears full, with minimal short-term earnings risk, suggesting limited upside potential in the near future. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.

Halma Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Halma Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £HLMA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jul10
Halma
Dividend·Ex-dividend
Aug15
Halma
Dividend·Payment
£0.1412Per share
FAQs